vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and MSC INDUSTRIAL DIRECT CO INC (MSM). Click either name above to swap in a different company.

MSC INDUSTRIAL DIRECT CO INC is the larger business by last-quarter revenue ($965.7M vs $487.7M, roughly 2.0× CLOVER HEALTH INVESTMENTS, CORP.). MSC INDUSTRIAL DIRECT CO INC runs the higher net margin — 5.4% vs -10.1%, a 15.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 4.0%). MSC INDUSTRIAL DIRECT CO INC produced more free cash flow last quarter ($7.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -3.4%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

MSC Industrial Direct Co., Inc (MSC), through its subsidiaries, primarily MSC Industrial Supply Co., is one of the largest industrial equipment distributors in the United States, distributing more than 1.5 million metalworking and other industrial products.

CLOV vs MSM — Head-to-Head

Bigger by revenue
MSM
MSM
2.0× larger
MSM
$965.7M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+40.7% gap
CLOV
44.7%
4.0%
MSM
Higher net margin
MSM
MSM
15.5% more per $
MSM
5.4%
-10.1%
CLOV
More free cash flow
MSM
MSM
$76.4M more FCF
MSM
$7.4M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-3.4%
MSM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
MSM
MSM
Revenue
$487.7M
$965.7M
Net Profit
$-49.3M
$51.8M
Gross Margin
40.7%
Operating Margin
-10.1%
7.9%
Net Margin
-10.1%
5.4%
Revenue YoY
44.7%
4.0%
Net Profit YoY
-123.2%
11.1%
EPS (diluted)
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
MSM
MSM
Q4 25
$487.7M
$965.7M
Q3 25
$496.6M
$978.2M
Q2 25
$477.6M
$971.1M
Q1 25
$462.3M
Q4 24
$337.0M
$928.5M
Q3 24
$331.0M
Q2 24
$356.3M
$979.4M
Q1 24
$346.9M
$935.3M
Net Profit
CLOV
CLOV
MSM
MSM
Q4 25
$-49.3M
$51.8M
Q3 25
$-24.4M
$56.5M
Q2 25
$-10.6M
$56.8M
Q1 25
$-1.3M
Q4 24
$-22.1M
$46.6M
Q3 24
$-9.2M
Q2 24
$7.4M
$71.7M
Q1 24
$-19.2M
$61.8M
Gross Margin
CLOV
CLOV
MSM
MSM
Q4 25
40.7%
Q3 25
40.4%
Q2 25
41.0%
Q1 25
Q4 24
40.7%
Q3 24
24.5%
Q2 24
30.3%
40.9%
Q1 24
23.6%
41.5%
Operating Margin
CLOV
CLOV
MSM
MSM
Q4 25
-10.1%
7.9%
Q3 25
-4.9%
8.6%
Q2 25
-2.2%
8.5%
Q1 25
-0.3%
Q4 24
-6.4%
7.8%
Q3 24
-2.7%
Q2 24
2.0%
10.9%
Q1 24
-6.5%
9.7%
Net Margin
CLOV
CLOV
MSM
MSM
Q4 25
-10.1%
5.4%
Q3 25
-4.9%
5.8%
Q2 25
-2.2%
5.9%
Q1 25
-0.3%
Q4 24
-6.6%
5.0%
Q3 24
-2.8%
Q2 24
2.1%
7.3%
Q1 24
-5.5%
6.6%
EPS (diluted)
CLOV
CLOV
MSM
MSM
Q4 25
$0.93
Q3 25
$1.02
Q2 25
$1.02
Q1 25
Q4 24
$0.83
Q3 24
Q2 24
$1.27
Q1 24
$1.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
MSM
MSM
Cash + ST InvestmentsLiquidity on hand
$78.3M
$40.3M
Total DebtLower is stronger
$214.1M
Stockholders' EquityBook value
$308.7M
$1.4B
Total Assets
$541.0M
$2.5B
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
MSM
MSM
Q4 25
$78.3M
$40.3M
Q3 25
$56.2M
Q2 25
$71.7M
Q1 25
Q4 24
$194.5M
$57.3M
Q3 24
$288.0M
Q2 24
$254.8M
$25.9M
Q1 24
$208.3M
$22.2M
Total Debt
CLOV
CLOV
MSM
MSM
Q4 25
$214.1M
Q3 25
$168.8M
Q2 25
$285.0M
Q1 25
Q4 24
$289.9M
Q3 24
Q2 24
$299.8M
Q1 24
$294.5M
Stockholders' Equity
CLOV
CLOV
MSM
MSM
Q4 25
$308.7M
$1.4B
Q3 25
$340.9M
$1.4B
Q2 25
$344.2M
$1.4B
Q1 25
$336.1M
Q4 24
$341.1M
$1.4B
Q3 24
$342.2M
Q2 24
$324.9M
$1.4B
Q1 24
$292.5M
$1.4B
Total Assets
CLOV
CLOV
MSM
MSM
Q4 25
$541.0M
$2.5B
Q3 25
$559.7M
$2.5B
Q2 25
$575.0M
$2.5B
Q1 25
$583.7M
Q4 24
$580.7M
$2.5B
Q3 24
$653.0M
Q2 24
$674.2M
$2.5B
Q1 24
$671.8M
$2.5B
Debt / Equity
CLOV
CLOV
MSM
MSM
Q4 25
0.16×
Q3 25
0.12×
Q2 25
0.21×
Q1 25
Q4 24
0.21×
Q3 24
Q2 24
0.21×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
MSM
MSM
Operating Cash FlowLast quarter
$-66.9M
$29.4M
Free Cash FlowOCF − Capex
$-69.0M
$7.4M
FCF MarginFCF / Revenue
-14.1%
0.8%
Capex IntensityCapex / Revenue
0.4%
2.3%
Cash ConversionOCF / Net Profit
0.57×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
MSM
MSM
Q4 25
$-66.9M
$29.4M
Q3 25
$12.1M
Q2 25
$5.4M
$151.6M
Q1 25
$-16.3M
Q4 24
$34.8M
$101.9M
Q3 24
$50.0M
Q2 24
$44.8M
$143.5M
Q1 24
$25.9M
$78.7M
Free Cash Flow
CLOV
CLOV
MSM
MSM
Q4 25
$-69.0M
$7.4M
Q3 25
$11.4M
Q2 25
$4.8M
$100.7M
Q1 25
$-16.5M
Q4 24
$33.3M
$81.7M
Q3 24
$49.6M
Q2 24
$44.4M
$114.0M
Q1 24
$25.5M
$53.4M
FCF Margin
CLOV
CLOV
MSM
MSM
Q4 25
-14.1%
0.8%
Q3 25
2.3%
Q2 25
1.0%
10.4%
Q1 25
-3.6%
Q4 24
9.9%
8.8%
Q3 24
15.0%
Q2 24
12.5%
11.6%
Q1 24
7.3%
5.7%
Capex Intensity
CLOV
CLOV
MSM
MSM
Q4 25
0.4%
2.3%
Q3 25
0.1%
Q2 25
0.1%
5.2%
Q1 25
0.0%
Q4 24
0.5%
2.2%
Q3 24
0.1%
Q2 24
0.1%
3.0%
Q1 24
0.1%
2.7%
Cash Conversion
CLOV
CLOV
MSM
MSM
Q4 25
0.57×
Q3 25
Q2 25
2.67×
Q1 25
Q4 24
2.18×
Q3 24
Q2 24
6.04×
2.00×
Q1 24
1.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons